| A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia (NCT06113289) | M.D. Anderson Cancer Center | 2024-02-08 |
| Cladribine Venetoclax in Monocytic AML (NCT06232655) | University of Colorado, Denver | 2024-02-08 |
| Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (NCT06067737) | Johns Hopkins University | 2024-02-08 |
| DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) (NCT06034938) | University Hospital, Caen | 2024-02-08 |
| Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors (NCT06169124) | National Cancer Institute (NCI) | 2024-02-08 |
| T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma (NCT06157541) | Queensland Institute of Medical Research | 2024-02-08 |
| Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain (NCT06247813) | Ethos Research & Development | 2024-02-08 |
| Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NCT06249854) | Korea Institute of Oriental Medicine | 2024-02-08 |
| FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae (NCT05791396) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2024-02-08 |
| Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (NCT05975983) | InSilico Medicine Hong Kong Limited | 2024-02-08 |
| A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer (NCT06095505) | Puma Biotechnology, Inc. | 2024-02-08 |
| A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients (NCT06133010) | ModernaTX, Inc. | 2024-02-08 |
| VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1 (NCT06214052) | ViiV Healthcare | 2024-02-07 |
| Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment. (NCT06247735) | Kowa Research Institute, Inc. | 2024-02-07 |
| Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss (NCT06029673) | Stanford University | 2024-02-07 |
| HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients (NCT05550662) | The Hospital for Sick Children | 2024-02-07 |
| BXOS110 Injection in the Treatment of Acute Ischaemic Stroke (NCT06322394) | Biocells (Beijing) Biotech Co.,Ltd | 2024-02-07 |
| A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies (NCT06045910) | Cancer Research UK | 2024-02-07 |
| A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes (NCT06196203) | Akeso | 2024-02-07 |
| Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC (NCT06260553) | Fujian Cancer Hospital | 2024-02-07 |
| A Study of HS-20094 in Patients With T2DM (NCT06901648) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-02-06 |
| TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD)) (NCT06169722) | Beijing Tide Pharmaceutical Co., Ltd | 2024-02-06 |
| Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) (NCT06377267) | Vall d'Hebron Institute of Oncology | 2024-02-06 |
| A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease (NCT06225973) | Telios Pharma, Inc. | 2024-02-06 |
| Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma (NCT06164275) | Northwestern University | 2024-02-06 |
| CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients (NCT06262438) | Princess Maxima Center for Pediatric Oncology | 2024-02-06 |
| Cough Reduction in IPF With Nalbuphine ER (NCT05964335) | Trevi Therapeutics | 2024-02-06 |
| HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors (NCT06112704) | Hansoh BioMedical R&D Company | 2024-02-06 |
| Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT06238544) | Chengdu Suncadia Medicine Co., Ltd. | 2024-02-06 |
| MDMA for AUD/PTSD Comorbidity (NCT05943665) | Carolina L Haass-Koffler | 2024-02-06 |
| A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC (NCT06246110) | Eikon Therapeutics | 2024-02-06 |
| RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL. (NCT06250959) | Chen Suning | 2024-02-05 |
| LAssa Fever Adjunct Treatment With DEXamethasone (NCT06222723) | Bernhard Nocht Institute for Tropical Medicine | 2024-02-05 |
| Stellate Ganglion Block as Novel Treatment for Heart Failure Patients (NCT06244056) | Mina sobhi said fam | 2024-02-05 |
| Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer (NCT06204094) | Jinhua Central Hospital | 2024-02-05 |
| Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin (NCT06341426) | University Health Network, Toronto | 2024-02-05 |
| Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients (NCT06199037) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-02-05 |
| A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight (NCT06230523) | Eli Lilly and Company | 2024-02-05 |
| T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT05894824) | Yonsei University | 2024-02-05 |
| Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction (NCT06125054) | Dr. med. Marcus Herdener | 2024-02-05 |
| A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers (NCT05910827) | Hummingbird Bioscience | 2024-02-05 |
| Mirdametinib in Histiocytic Disorders (NCT06153173) | Children's Hospital Medical Center, Cincinnati | 2024-02-05 |
| Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes (NCT05957055) | Medical University of Lodz | 2024-02-05 |
| Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients (NCT06126497) | Suven Life Sciences Limited | 2024-02-05 |
| A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer (NCT06198751) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-02-05 |
| PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6 (NCT06241547) | Peking Union Medical College Hospital | 2024-02-05 |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer (NCT05704829) | Women's Cancer Study Group GmbH | 2024-02-05 |
| Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation (NCT06243354) | Sichuan Huiyu Pharmaceutical Co., Ltd | 2024-02-04 |
| Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study (NCT06241469) | Wu Jun | 2024-02-03 |
| Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study (NCT05987241) | National Cancer Institute (NCI) | 2024-02-02 |
| Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. (NCT05962606) | Aptarion Biotech AG | 2024-02-02 |
| Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC) (NCT06097468) | University of California, San Francisco | 2024-02-02 |
| Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults (NCT05207085) | Yale University | 2024-02-02 |
| Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment (NCT06238024) | Suzhou Municipal Hospital of Anhui Province | 2024-02-02 |
| Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression (NCT06749860) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-02-02 |
| Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder (NCT05421065) | Peggy C Nopoulos | 2024-02-02 |
| Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma (NCT06257017) | Yung NA | 2024-02-02 |
| Efficacy of a Herbal Formula for Bone Metastases (NCT06023420) | Chinese University of Hong Kong | 2024-02-01 |
| Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma (NCT06178588) | University of Kansas Medical Center | 2024-02-01 |
| A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT06241599) | Sun Yat-sen University | 2024-02-01 |
| ctDNA in HER2+ EBC Neoadjuvant Treatment (NCT07335081) | Shanghai Jiao Tong University School of Medicine | 2024-02-01 |
| Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion (NCT05759481) | Milton S. Hershey Medical Center | 2024-02-01 |
| A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer (NCT06123338) | Memorial Sloan Kettering Cancer Center | 2024-02-01 |
| Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX (NCT06210360) | Changhai Hospital | 2024-02-01 |
| A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer (NCT06251973) | Memorial Sloan Kettering Cancer Center | 2024-02-01 |
| Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) (NCT06352281) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2024-02-01 |
| NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients (NCT06000748) | University of California, San Francisco | 2024-02-01 |
| A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension (NCT06177678) | Kukje Pharma | 2024-02-01 |
| Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients (NCT06265077) | Noha Mansour | 2024-02-01 |
| Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer (NCT06210971) | Hebei Medical University Fourth Hospital | 2024-02-01 |
| Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise (NCT04992247) | Sorrento Therapeutics, Inc. | 2024-02-01 |
| Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients (NCT03947437) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2024-02-01 |
| Pharmacokinetics of Inhaled Levosimendan (NCT06387862) | Universitair Ziekenhuis Brussel | 2024-02-01 |
| Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA (NCT06254287) | Institute of Hematology & Blood Diseases Hospital, China | 2024-02-01 |
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients (NCT06469853) | Medibiofarma S.L. | 2024-02-01 |
| VAC Regimen for AML Patients Who Failed to Response to VA Regimen (NCT06220162) | The First Affiliated Hospital of Soochow University | 2024-02-01 |
| Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations (NCT06054191) | Sun Yat-sen University | 2024-02-01 |
| Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers (NCT04186559) | Silk Road Therapies, Inc. | 2024-02-01 |
| Efficacy of IVMED-85 on Pediatric Myopia (NCT05761795) | iVeena Delivery Systems, Inc. | 2024-02-01 |
| SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma (NCT06199882) | Zhejiang Cancer Hospital | 2024-02-01 |
| Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control (NCT06523504) | Ruihua Wei | 2024-02-01 |
| A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough (NCT06213363) | Beijing Tide Pharmaceutical Co., Ltd | 2024-02-01 |
| Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control (NCT05477875) | University of Florida | 2024-02-01 |
| Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure (NCT06002841) | D'Or Institute for Research and Education | 2024-02-01 |
| Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study (NCT07583511) | Sun Yat-sen University | 2024-02-01 |
| An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC (NCT06332300) | Jiangsu Province Nanjing Brain Hospital | 2024-02-01 |
| Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) (NCT05853575) | Mirati Therapeutics Inc. | 2024-02-01 |
| PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma (NCT06696742) | The First Affiliated Hospital with Nanjing Medical University | 2024-02-01 |
| Neoadjuvant PSMA-RLT in Oligometastatic PCa (NCT06259123) | Medical University of Vienna | 2024-02-01 |
| Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors (NCT06221774) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-02-01 |
| Oxygen Targets in Acute Heart Failure With Pulmonary Congestion (NCT05613218) | Copenhagen University Hospital, Hvidovre | 2024-02-01 |
| Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma (NCT06217003) | The First Affiliated Hospital of Xinxiang Medical College | 2024-02-01 |
| Good Nights Sleep Program to Improve Child and Family Sleep (NCT06249217) | Auburn University | 2024-02-01 |
| Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS (NCT03696485) | Stem Cell Medicine Ltd. | 2024-02-01 |
| RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations (NCT06185400) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-02-01 |
| Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL (NCT06578546) | The First Affiliated Hospital of Soochow University | 2024-02-01 |
| Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial (NCT06235398) | Assistance Publique - Hôpitaux de Paris | 2024-02-01 |
| Perioperative Efgartigimod for Thymoma and Myasthenia Gravis (NCT06221501) | Shanghai Zhongshan Hospital | 2024-02-01 |
| A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF (NCT06237335) | ReCode Therapeutics | 2024-02-01 |
| Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation. (NCT05953142) | Federal University of São Paulo | 2024-02-01 |